Pulse oximeter and spirometer market seen reaching $6.37 billion by 2030

The Business Research Company projects the global pulse oximeters and spirometers market will grow from $4.73 billion in 2026 to $6.37 billion by 2030. Demand is being lifted by remote respiratory monitoring, telehealth adoption, home healthcare expansion and broader use of AI-powered analytics.

Why it matters: - Pulse oximeters and spirometers are becoming more important as respiratory disease rates rise and care shifts toward remote monitoring. - The market’s projected growth signals more demand for non-invasive tools used to track oxygen levels and lung function in hospitals, homes and telehealth settings. - The report points to a larger move toward preventive respiratory diagnostics and earlier disease detection.

What happened: - The Business Research Company released its "Pulse Oximeters, Spirometers Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035." - The market is estimated at $4.73 billion in 2026, up from $4.37 billion in 2025. - The report forecasts the market will reach $6.37 billion by 2030. - The forecast implies a 7.7% compound annual growth rate through 2030. - North America held the largest market share in 2025. - Asia-Pacific ranked as the second-largest market in 2025.

The details: - Historical growth was driven by rising respiratory illness prevalence, greater awareness of lung health and broader hospital use of respiratory monitoring. - Wider acceptance of non-invasive diagnostic tools and increased clinical use of spirometry also supported recent expansion. - Future growth is expected from remote respiratory monitoring, telehealth-enabled respiratory devices and home healthcare services. - AI-powered respiratory data analytics is emerging as another growth driver. - Key trends include portable monitoring devices, home oxygen monitoring, connected spirometry platforms, multiparameter respiratory monitoring and early disease detection. - Pulse oximeters measure blood oxygen saturation without invasive procedures. - Spirometers measure how much air the lungs inhale and exhale and the rate of airflow during exhalation. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The COVID-19 pandemic increased demand for respiratory devices because oxygen therapy became critical for severe cases. - The World Health Organization reported 771,191,203 confirmed COVID-19 cases worldwide and 6,961,014 deaths in October 2023. - The report’s 2026 edition also includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.

Between the lines: - The market outlook reflects a healthcare shift from episodic diagnosis toward continuous monitoring outside traditional clinical settings. - Stronger adoption of connected and AI-enabled devices suggests vendors are competing on data integration as much as on hardware. - The regional ranking suggests North America remains the most mature market, while Asia-Pacific continues to scale as respiratory care access expands.

What's next: - The forecast period points to continued gains in portable and connected respiratory devices. - Home-based monitoring and telehealth workflows are likely to take a larger share of use cases. - More emphasis on early detection and data analytics should shape product development and investment through 2030. - More information is available in the full report and a free sample.